Table 5.
Clinicopathological characteristics with ATP7B protein expression in 89 NSCLC patients who underwent surgical resection.
| Characteristics | All patients | ATP7B (+) n (%) |
ATP7B (-) n (%) |
p value |
|---|---|---|---|---|
| All patients | 89 (100.0) | 38 (42.7) | 51 (57.3) | |
| Age | ||||
| <60 years | 57 (64.0) | 24 (63.2) | 33 (64.7) | 0.880 |
| ≧60years | 32 (36.0) | 14 (36.8) | 18 (35.3) | |
| Gender | ||||
| Male | 45 (50.6) | 21 (55.3) | 24 (47.1) | 0.444 |
| Female | 44 (49.4) | 17 (44.7) | 27 (52.9) | |
| Histology | ||||
| Adenocarcinoma | 45 (50.6) | 23 (60.5) | 22 (43.1) | 0.240 |
| Squamous cell carcinoma | 42 (47.2) | 14 (36.8) | 28 (54.9) | |
| Adenosquamous | 2 (2.2) | 1 (2.7) | 1 (2.0) | |
| Clinical stage | ||||
| I-II | 38 (42.7) | 20 (52.6) | 18 (35.3) | 0.102 |
| III-IV | 51 (57.3) | 18 (47.4) | 33 (64.7) | |
| Differentiation | ||||
| Poor | 30 (33.7) | 14 (36.8) | 16 (31.4) | 0.712 |
| Moderate | 34 (38.2) | 15 (39.5) | 19 (37.2) | |
| Well | 25 (28.1) | 9 (23.7) | 16 (31.4) |